PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).
Liu MC, Pitcher BN, Mardis ER, Davies SR, Friedman PN, Snider JE, Vickery TL, Reed JP, DeSchryver K, Singh B, Gradishar WJ, Perez EA, Martino S, Citron ML, Norton L, Winer EP, Hudis CA, Carey LA, Bernard PS, Nielsen TO, Perou CM, Ellis MJ, Barry WT.
Liu MC, et al. Among authors: friedman pn.
NPJ Breast Cancer. 2016;2:15023-. doi: 10.1038/npjbcancer.2015.23. Epub 2016 Jan 6.
NPJ Breast Cancer. 2016.
PMID: 28691057
Free PMC article.